EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | IBRO Neuroscience Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242123005353 |
_version_ | 1797636420128473088 |
---|---|
author | Mari Paz Serrano-Regal Leticia Calahorra Inmaculada Alonso-García Ursula Boschert Philipp Haselmayer María Cristina Ortega Isabel Machin-Diaz Celia Camacho-Toledano Jennifer García-Arocha Diego Clemente |
author_facet | Mari Paz Serrano-Regal Leticia Calahorra Inmaculada Alonso-García Ursula Boschert Philipp Haselmayer María Cristina Ortega Isabel Machin-Diaz Celia Camacho-Toledano Jennifer García-Arocha Diego Clemente |
author_sort | Mari Paz Serrano-Regal |
collection | DOAJ |
first_indexed | 2024-03-11T12:35:03Z |
format | Article |
id | doaj.art-dc97177e5f804c3a870196ab8fda9aa9 |
institution | Directory Open Access Journal |
issn | 2667-2421 |
language | English |
last_indexed | 2024-03-11T12:35:03Z |
publishDate | 2023-10-01 |
publisher | Elsevier |
record_format | Article |
series | IBRO Neuroscience Reports |
spelling | doaj.art-dc97177e5f804c3a870196ab8fda9aa92023-11-06T04:23:02ZengElsevierIBRO Neuroscience Reports2667-24212023-10-0115S272S273EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSISMari Paz Serrano-Regal0Leticia Calahorra1Inmaculada Alonso-García2Ursula Boschert3Philipp Haselmayer4María Cristina Ortega5Isabel Machin-Diaz6Celia Camacho-Toledano7Jennifer García-Arocha8Diego Clemente9Hospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, SpainHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, SpainHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, SpainMerck KGaA, Ares Trading Sa, Eysins, SwitzerlandMerck KGaA, Immunology, Darmstadt, GermanyHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, Spain; Centro de investigación Biomédica en Red-Enfermedades Neurodegenerativas (CIBERNED), Neuroimmuno-repair Group, Madrid, SpainHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, Spain; Centro de investigación Biomédica en Red-Enfermedades Neurodegenerativas (CIBERNED), Neuroimmuno-repair Group, Madrid, SpainHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, Spain; Centro de investigación Biomédica en Red-Enfermedades Neurodegenerativas (CIBERNED), Neuroimmuno-repair Group, Madrid, SpainHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, SpainHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, Spain; Centro de investigación Biomédica en Red-Enfermedades Neurodegenerativas (CIBERNED), Neuroimmuno-repair Group, Madrid, Spainhttp://www.sciencedirect.com/science/article/pii/S2667242123005353 |
spellingShingle | Mari Paz Serrano-Regal Leticia Calahorra Inmaculada Alonso-García Ursula Boschert Philipp Haselmayer María Cristina Ortega Isabel Machin-Diaz Celia Camacho-Toledano Jennifer García-Arocha Diego Clemente EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS IBRO Neuroscience Reports |
title | EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS |
title_full | EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS |
title_fullStr | EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS |
title_full_unstemmed | EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS |
title_short | EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS |
title_sort | evobrutinib treatment reduces the damage to the cns and increases the number of classical dendritic cells in experimental multiple sclerosis |
url | http://www.sciencedirect.com/science/article/pii/S2667242123005353 |
work_keys_str_mv | AT maripazserranoregal evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis AT leticiacalahorra evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis AT inmaculadaalonsogarcia evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis AT ursulaboschert evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis AT philipphaselmayer evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis AT mariacristinaortega evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis AT isabelmachindiaz evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis AT celiacamachotoledano evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis AT jennifergarciaarocha evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis AT diegoclemente evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis |